Lifeward (NasdaqCM:LFWD) Q4 2025 Earnings call March 18, 2026 08:30 AM ET Company ParticipantsAlmog Adar - CFOMark Grant - President and CEOConference Call ParticipantsSwayampakula Ramakanth - Managing Director and Senior Equity Research AnalystYale Jen - Managing Director and Senior Biotechnology AnalystOperatorGood day, and welcome to the Lifeward Inc fourth quarter 2025 earnings conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialis ...

Advancing transformation into a diversified biomedical innovation company with a clear path to cash flow positive Oramed strategic transaction receives shareholder approval; Lifeward gains new oral protein delivery technology platform Lifeward already executing new strategy through acquisition of powered upper-body exoskeleton technology Lower operating expenses and cash usage reflect improved operational efficiency HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 18, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. ...